Table 4 |
|||
|
Median value of titers in AS patients versus controls and results of Z-testing |
|||
|
Antibody |
Median value of titer in AS patients |
Median value of titer in control patients |
P value |
|
|
|||
|
IgA ASCA |
1.24 |
1.10 |
0.28 |
|
IgG ASCA |
4.70 |
4.05 |
0.29 |
|
Anti-I2 |
11.78 |
7.86 |
0.0172 |
|
Anti-OmpC |
8.61 |
7.70 |
0.30 |
|
Anti-CBir1 |
16.26 |
15.05 |
0.63 |
|
ANCA |
11.6 |
12.1 |
0.65 |
|
|
|||
|
The median value of Anti-I2 in AS patients is significantly increased when compared to controls (shown in bold and italics). ANCA = antineutrophil cytoplasmic antibodies; anti-CBir1 = anti-flagellin; anti-OmpC = anti-Escherichia coli outer membrane porin C; AS = ankylosing spondylitis; ASCA = Anti-Saccharomyces cerevisiae antibody. |
|||
|
Mundwiler et al. Arthritis Research & Therapy 2009 11:R177 doi:10.1186/ar2866 |
|||